Sheela Foam Ltd
Sheela Foam Limited is a leading player in India’s mattress and foam products industry and a leader in Polyurethane (PU) Foam. It has a nationwide presence in manufacturing PU Foam with a track record, since 1971. [1]
- Market Cap ₹ 7,120 Cr.
- Current Price ₹ 655
- High / Low ₹ 1,067 / 618
- Stock P/E 88.9
- Book Value ₹ 279
- Dividend Yield 0.00 %
- ROCE 4.39 %
- ROE 2.69 %
- Face Value ₹ 5.00
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 10.1% over past five years.
- Company has a low return on equity of 5.98% over last 3 years.
- Earnings include an other income of Rs.162 Cr.
- Promoter holding has decreased over last 3 years: -7.26%
- Working capital days have increased from 32.3 days to 65.4 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Consumer Durables Industry: Miscellaneous
Part of BSE 500 BSE SmallCap BSE Allcap BSE Consumer Discretionary BSE 250 SmallCap Index
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1,221 | 1,359 | 1,550 | 1,680 | 1,889 | 2,066 | 2,121 | 2,437 | 2,866 | 2,873 | 2,982 | 3,439 | |
1,136 | 1,268 | 1,374 | 1,484 | 1,672 | 1,855 | 1,821 | 2,073 | 2,550 | 2,575 | 2,678 | 3,189 | |
Operating Profit | 85 | 91 | 176 | 196 | 217 | 211 | 300 | 364 | 315 | 298 | 304 | 250 |
OPM % | 7% | 7% | 11% | 12% | 11% | 10% | 14% | 15% | 11% | 10% | 10% | 7% |
0 | 11 | 16 | 23 | 21 | 28 | 28 | 50 | 79 | 86 | 136 | 162 | |
Interest | 19 | 16 | 12 | 11 | 9 | 10 | 13 | 18 | 17 | 21 | 69 | 121 |
Depreciation | 30 | 28 | 29 | 30 | 35 | 40 | 59 | 73 | 81 | 90 | 116 | 183 |
Profit before tax | 36 | 58 | 152 | 178 | 193 | 189 | 256 | 324 | 296 | 273 | 256 | 108 |
Tax % | 23% | 26% | 31% | 29% | 31% | 29% | 24% | 26% | 26% | 26% | 24% | 12% |
28 | 43 | 105 | 126 | 134 | 134 | 194 | 240 | 219 | 201 | 184 | 97 | |
EPS in Rs | 8.57 | 13.13 | 32.22 | 12.86 | 13.70 | 13.70 | 19.82 | 24.36 | 22.27 | 20.39 | 16.78 | 8.84 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 10% |
5 Years: | 10% |
3 Years: | 6% |
TTM: | 15% |
Compounded Profit Growth | |
---|---|
10 Years: | 6% |
5 Years: | -16% |
3 Years: | -27% |
TTM: | -42% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | -1% |
3 Years: | -25% |
1 Year: | -29% |
Return on Equity | |
---|---|
10 Years: | 13% |
5 Years: | 9% |
3 Years: | 6% |
Last Year: | 3% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 16 | 16 | 16 | 24 | 24 | 24 | 24 | 24 | 24 | 49 | 54 | 54 |
Reserves | 180 | 229 | 322 | 439 | 573 | 706 | 895 | 1,160 | 1,368 | 1,549 | 2,866 | 2,981 |
188 | 146 | 115 | 59 | 48 | 31 | 310 | 334 | 466 | 571 | 1,493 | 1,462 | |
241 | 289 | 335 | 395 | 398 | 401 | 414 | 551 | 496 | 533 | 909 | 970 | |
Total Liabilities | 625 | 679 | 788 | 918 | 1,043 | 1,162 | 1,644 | 2,069 | 2,355 | 2,702 | 5,322 | 5,467 |
252 | 286 | 288 | 318 | 348 | 412 | 851 | 894 | 883 | 865 | 3,129 | 3,155 | |
CWIP | 17 | 8 | 10 | 36 | 52 | 1 | 18 | 33 | 120 | 287 | 166 | 131 |
Investments | 0 | 0 | 10 | 0 | 98 | 318 | 231 | 411 | 618 | 768 | 878 | 873 |
356 | 385 | 481 | 564 | 544 | 432 | 544 | 732 | 734 | 781 | 1,150 | 1,309 | |
Total Assets | 625 | 679 | 788 | 918 | 1,043 | 1,162 | 1,644 | 2,069 | 2,355 | 2,702 | 5,322 | 5,467 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
124 | 147 | 159 | 122 | 134 | 138 | 157 | 254 | 197 | 218 | 406 | 252 | |
-27 | -49 | -34 | 2 | -80 | -246 | -287 | -208 | -306 | -272 | -2,258 | -29 | |
-53 | -59 | -25 | -67 | -20 | -27 | 157 | -32 | 93 | 56 | 1,854 | -226 | |
Net Cash Flow | 45 | 40 | 100 | 57 | 34 | -135 | 27 | 13 | -17 | 1 | 2 | -3 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 36 | 31 | 28 | 30 | 28 | 27 | 37 | 45 | 34 | 36 | 45 | 37 |
Inventory Days | 61 | 52 | 49 | 59 | 60 | 60 | 81 | 87 | 64 | 71 | 73 | 64 |
Days Payable | 57 | 57 | 52 | 64 | 51 | 46 | 55 | 91 | 58 | 55 | 83 | 66 |
Cash Conversion Cycle | 40 | 26 | 24 | 25 | 37 | 41 | 63 | 41 | 40 | 51 | 34 | 35 |
Working Capital Days | 19 | -3 | -10 | -4 | 7 | 14 | 28 | 28 | 30 | 25 | 7 | 65 |
ROCE % | 14% | 19% | 38% | 39% | 35% | 28% | 26% | 23% | 18% | 14% | 8% | 4% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
1d - Transcript for Conference Call on May 15, 2025
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
15 May - Link to audio recording of Q4 and FY25 investors' conference call provided.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
15 May - Investor meeting scheduled on May 20, 2025 at Centrum Conference, no UPSI to be discussed.
- Announcement under Regulation 30 (LODR)-Investor Presentation 14 May
-
Board Meeting Outcome for Financial Results For The Quarter And Year Ended March 2025
14 May - Sheela Foam reports audited FY25 financials; CEO resigns, MD assumes CEO duties; unmodified audit opinion.
Annual reports
Concalls
-
May 2025Transcript PPT
-
Mar 2025TranscriptNotesPPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
Aug 2024TranscriptNotesPPT
-
May 2024Transcript PPT
-
Mar 2024TranscriptNotesPPT
-
Feb 2024TranscriptPPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
Aug 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jul 2023TranscriptNotesPPT
-
Jul 2023TranscriptNotesPPT
-
May 2023Transcript PPT
-
Feb 2023TranscriptPPT
-
Feb 2023Transcript PPT
-
Dec 2022Transcript PPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
May 2022Transcript PPT
-
May 2022TranscriptNotesPPT
-
Mar 2022Transcript PPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021TranscriptPPT
-
Aug 2021TranscriptPPT
-
Jun 2021TranscriptPPT
-
Feb 2021TranscriptPPT
-
Nov 2020TranscriptPPT
-
Aug 2020TranscriptPPT
-
Jun 2020TranscriptPPT
-
Feb 2020TranscriptPPT
-
Nov 2019TranscriptPPT
-
Aug 2019TranscriptPPT
-
May 2019TranscriptPPT
-
Mar 2019TranscriptPPT
-
Oct 2018TranscriptPPT
-
Aug 2018TranscriptPPT
-
May 2018TranscriptPPT
-
Jan 2018TranscriptPPT
-
Oct 2017TranscriptPPT
Largest Manufacturer of Polyurethane Foam
The company is India's largest manufacturer of flexible slab stock Polyutherane (PU) foam and mattresses under Sleepwell, Furlenco, and Kurlon [1] with a 30% market share in India’s mattress segment and a 40% market share in Australia. The Kurlon brand holds a 12-13% market share of the modern mattress market.[2] [3] [4]